FERMENTALG (ALGAE.PA)
EUR 0.32
(-0.62%)
EUR 0.32
(-0.62%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.32 EUR | -33.33% |
| 2022 | -0.24 EUR | -26.32% |
| 2021 | -0.19 EUR | 40.63% |
| 2020 | -0.32 EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.05 EUR | 0.0% |
| 2024 Q1 | -0.05 EUR | 46.7% |
| 2023 Q4 | -0.09 EUR | 0.0% |
| 2023 FY | - EUR | -33.33% |
| 2023 Q3 | -0.09 EUR | -40.0% |
| 2023 Q2 | -0.07 EUR | 0.0% |
| 2023 Q1 | -0.07 EUR | -21.6% |
| 2022 FY | - EUR | -26.32% |
| 2022 Q4 | -0.06 EUR | 0.0% |
| 2021 FY | - EUR | 40.63% |
| 2020 FY | - EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Nicox S.A. | -0.42 EUR | 23.81% |
| European Medical Solutions | -0.00 EUR | -63900.0% |
| argenx SE | -4.67 EUR | 93.148% |
| BioSenic S.A. | -0.21 EUR | -52.381% |
| Celyad Oncology SA | -0.33 EUR | 3.03% |
| Hyloris Pharmaceuticals SA | -0.55 EUR | 41.818% |
| Onward Medical N.V. | -1.20 EUR | 73.333% |
| Oxurion NV | -0.01 EUR | -2682.609% |
| PHAXIAM Therapeutics S.A. | -5.00 EUR | 93.6% |
| Financière de Tubize SA | 1.98 EUR | 116.162% |
| UCB SA | 1.81 EUR | 117.68% |